title: Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Stevens
authors.forename: Steven
authors.initials: S
authors.lastname: Rapaport
authors.forename: Laura
authors.initials: L
authors.lastname: Maroldo-Connelly
authors.forename: James B
authors.initials: JB
authors.lastname: Patterson
authors.forename: Richard
authors.initials: R
authors.lastname: Bertz
mesh_terms: D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D008297:Male; D008691:Methadone / Q000008:administration & dosage*; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage*; D011744:Pyrimidinones / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use
chemical_list: D017320:HIV Protease Inhibitors; D009294:Narcotics; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir; D008691:Methadone